ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > LYPD3

LYPD3

概要

Name:Ly6/PLAUR domain-containing protein 3
Target Synonym:C4.4A,GPI-Anchored Metastasis-Associated Protein Homolog,2310061G07Rik,GPI-Anchored Metastasis-Associated Protein C4.4A Homolog,MIG-C4,UNQ491/PRO1007,Ly6/PLAUR domain-containing protein 3,LYPD3,Matrigel-Induced Gene C4 Protein,LY6/PLAUR Domain Containing 3
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
LY3-H52H5 Human Human LYPD3 / C4.4A Protein, His Tag
LY3-H52H5-structure
LY3-H52H5-sds
ACRO Quality

生物活性データの一部

LY3-H52H5-MALS-HPLC
 LYPD3 ELISA

Immobilized Human LYPD3, His Tag (Cat. No. LY3-H52H5) at 1 μg/mL (100 μL/well) can bind various dilution ratio of Anti-LYPD3 Antibody (Rabbit Mab) (QC tested).

Synonym Name

LYPD3,MIG-C4,C4.4A

Background

Ly6/PLAUR domain-containing protein 3 (LYPD3) is also known as MIG-C4 ,C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog and Matrigel-induced gene C4 protein,which is a cell membrane protein containing two UPAR/Ly6 domains. LYPD3 is expressed in placenta, skin and urothelium. LYPD3 is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. LYPD3 play a role in supporting cell migration and it is not only probably involved in urothelial cell-matrix interactions, but also in tumor progression.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Lupartumab amadotin BAY-1129980 Phase 1 Clinical Bayer AG Neoplasms Details

This web search service is supported by Google Inc.

totopphone